Effectiveness of PSMA-Lutetium for Prostate Cancer Liver Metastases - Daniel Childs
Effectiveness of PSMA-Lutetium for Prostate Cancer Liver Metastases …
3 months ago
urotoday.com
Can PSMA PET Parameters Help Predict Toxicity and Outcomes in Patients Treated for mCRPC? | Diagnostic Imaging
Can PSMA PET Parameters Help Predict Toxicity and Outcomes in …
2 months ago
diagnosticimaging.com
Neoadjuvant and adjuvant ARPIs in high-risk localized #ProstateCancer. Robert Reiter, MD, UCLA Health joins Zach Klaassen, MD, MSc Georgia Cancer Center to discuss why surgery alone isn’t enough (recurrence up to 70%). Phase II data show better pathologic responses with ADT ARPIs, and phase III trials like PROTEUS and genomic-guided GUNS are underway, plus early signals from neoadjuvant Lu-177 PSMA (LuTectomy). Surgery systemic therapy may become a new paradigm. #WatchNow > bit.ly/4pAMUbk | UroT
1:59
Neoadjuvant and adjuvant ARPIs in high-risk localized #ProstateCanc…
18 views1 month ago
FacebookUroToday
Mel Gibson isn't lying…. A recent study documented COMPLETE REMISSION of Stage IV cancers
1:43
Mel Gibson isn't lying…. A recent study documented COMPLETE RE…
34 views1 month ago
YouTubeBusy 4 the Lord 2
💭 What is PSMA? Prostate-Specific Membrane Antigen (PSMA) is a protein that functions like a beacon and is highly expressed on most prostate cancer cells. It enables doctors to accurately locate and target cancer for both #imaging and #treatment. Watch the full video to learn about #PSMA and view our full resource on radiopharmaceuticals at zerocancer.org/radiopharmaceuticals. #ZEROProstateCancer #Radiopharmaceuticals | ZERO Prostate Cancer
0:42
💭 What is PSMA? Prostate-Specific Membrane Antigen (PSMA) is a pr…
2K views4 months ago
FacebookZERO Prostate Cancer
Arsenal v Chelsea (4-1 Pens) | Arsenal Fan Very Very Optimistic!
3:05
Arsenal v Chelsea (4-1 Pens) | Arsenal Fan Very Very Optimistic!
21.7K viewsAug 6, 2017
YouTubeAFTV
VIDEO: Lu-PSMA Radioligand Therapy - Prostate Cancer Patient Conference 2022
VIDEO: Lu-PSMA Radioligand Therapy - Prostate Cancer Patient …
Feb 16, 2023
uctv.tv
Lutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto) - UChic…
Jun 17, 2022
uchicagomedicine.org
0:27
Lu-PSMA is a game-changing treatment for men with advanced …
171 viewsSep 13, 2024
FacebookMovember Australia
0:26
PSMA—prostate-specific membrane antigen—is an important biomarke…
22.1K viewsSep 26, 2022
FacebookNovartis Cancer
PET PSMA for Prostate Cancer: Impact on Patient Journey | Urolo…
2K viewsMay 21, 2021
urologytimes.com
Dr. Morris on choosing between FDA-approved PSMA-PET imagin…
Aug 5, 2021
urologytimes.com
Dr. Morris on Logistical Challenges of Using 177Lu-PSMA-617 in Prost…
Jan 11, 2022
onclive.com
Diagnostic and Therapeutic Applications of PSMA in Prostate …
Jul 28, 2021
onclive.com
Use of PSMA PET Scans in Advanced Prostate Cancer | OncLi…
Jul 30, 2021
onclive.com
PSMA-Targeted Radioligand Therapy in Advanced Prostate Ca…
Jul 30, 2021
onclive.com
Advancements in Lutetium-PSMA Therapy for Prostate Cancer: Clini…
Oct 1, 2024
urotoday.com
Access to Cabazitaxel vs. 177Lu-PSMA-617 in mCRPC: Challenges …
4 months ago
vumedi.com
VISION Trial: Novel PSMA-Targeted Radiotherapy Improves Outcome…
Jul 26, 2021
ascopost.com
Potential Role of Lu-PSMA-617 in mCRPC | OncLive
1 week ago
onclive.com
Dr. Gafita on Sequencing 177Lu-PSMA-617 in mCRPC | OncLive
1 month ago
onclive.com
0:38
🇺🇸¹⁷⁷Lu-PSMA in an outpatient setting? What are the possible side effects…
5 views3 months ago
FacebookMinute Medical
0:30
A few weeks ago we hosted a webinar discussing PSMA-targete…
2K viewsMar 24, 2024
FacebookProstate Cancer Foundation
Efficacy and Toxicity of 177Lu-PSMA-617 for mCRPC: Results Fr…
108 viewsNov 20, 2024
vumedi.com
The VISION Study of 177Lu-PSMA-617 in mCRPC | OncLive
Aug 6, 2021
onclive.com
ESMO 2025 Insights: 177Lu-PSMA-617 With ADT + ARPI Improves rP…
25 views3 months ago
vumedi.com
ASCO® GU 2025 Insights: Efficacy of 177Lu-PSMA-617 /- ARPIs for th…
135 viewsMar 6, 2025
vumedi.com
ASCO® GU 2025 Insights: mCRPC Survival Outcomes With 177Lu-PS…
147 viewsFeb 25, 2025
vumedi.com
2:24
ECLIPSE - A Randomized Phase 3 Trial for 177-Lu-PSMA-I&T in patie…
5.7K viewsMar 17, 2023
FacebookSci Ani
ASCO® 2025 Insights: A Randomized Phase 2 FLEX-MRT T…
12 views9 months ago
vumedi.com
See more videos
Static thumbnail place holder